Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Sell
50
MKSI Quote, Financials, Valuation and Earnings
Last price:
$71.42
Seasonality move
:
3.55%
Day range:
$71.35 - $73.46
52-week range:
$54.84 - $147.40
Dividend yield:
1.23%
P/E ratio:
25.51x
P/S ratio:
1.35x
P/B ratio:
2.07x
Volume:
1.5M
Avg. volume:
1.8M
1-year change:
-41.98%
Market cap:
$4.8B
Revenue:
$3.6B
EPS (TTM):
$2.80
Analysts' Opinion
-
Consensus RatingMKS Instruments has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $121.96, MKS Instruments has an estimated upside of 70.71% from its current price of $71.44.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $70.00 representing 100% downside risk from its current price of $71.44.
Fair Value
-
According to the consensus of 9 analysts, MKS Instruments has 70.71% upside to fair value with a price target of $121.96 per share.
MKSI vs. S&P 500
-
Over the past 5 trading days, MKS Instruments has overperformed the S&P 500 by 12.1% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
MKS Instruments does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
MKS Instruments has grown year-over-year revenues for 1 quarter straight. In the most recent quarter MKS Instruments reported revenues of $934M.
Earnings Growth
-
MKS Instruments has grown year-over-year earnings for 1 quarter straight. In the most recent quarter MKS Instruments reported earnings per share of $1.33.
Enterprise value:
8.6B
EV / Invested capital:
--
Price / LTM sales:
1.35x
EV / EBIT:
17.04x
EV / Revenue:
2.41x
PEG ratio (5yr expected):
--
EV / Free cash flow:
21.07x
Price / Operating cash flow:
11.78x
Enterprise value / EBITDA:
10.10x
Gross Profit (TTM):
$1.7B
Return On Assets:
2.15%
Net Income Margin (TTM):
5.33%
Return On Equity:
8.06%
Return On Invested Capital:
2.68%
Operating Margin:
14.88%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $3.5B | $3.6B | $3.6B | $892M | $934M | |
| Gross Profit | $1.5B | $1.6B | $1.7B | $411M | $441M | |
| Operating Income | $672M | $385M | $517M | $110M | $139M | |
| EBITDA | $832M | -$1.1B | $855M | $125M | $235M | |
| Diluted EPS | $5.79 | -$27.55 | $2.80 | -$1.02 | $1.33 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.8B | $2.1B | $2.8B | $2.7B | $2.5B | |
| Total Assets | $3.9B | $4.5B | $11.5B | $9.1B | $8.6B | |
| Current Liabilities | $373.9M | $460M | $952M | $848M | $775M | |
| Total Liabilities | $1.5B | $1.7B | $7B | $6.6B | $6.3B | |
| Total Equity | $2.4B | $2.9B | $4.5B | $2.5B | $2.3B | |
| Total Debt | $829.5M | $817M | $4.9B | $4.8B | $4.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $529M | $319M | $528M | $181M | $176M | |
| Cash From Investing | -$4.6B | -$84M | -$117M | -$34M | -$51M | |
| Cash From Financing | $4B | -$259M | -$549M | -$143M | -$246M | |
| Free Cash Flow | $365M | $232M | $410M | $147M | $125M | |
MKSI
Sector
Market Cap
$4.8B
$78.1M
Price % of 52-Week High
48.47%
57.42%
Dividend Yield
1.23%
0%
Shareholder Yield
--
0.76%
1-Year Price Total Return
-41.98%
-18.92%
Beta (5-Year)
1.809
0.874
Dividend yield:
1.23%
Annualized payout:
$0.88
Payout ratio:
30.89%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$68.56
200-day SMA
Sell
Level
$104.90
Bollinger Bands (100)
Sell
Level
78.52 - 114.72
Chaikin Money Flow
Buy
Level
61.9M
20-day SMA
Buy
Level
$67.93
Relative Strength Index (RSI14)
Sell
Level
47.97
ADX Line
Buy
Level
19.14
Williams %R
Neutral
Level
-23.7397
50-day SMA
Sell
Level
$81.61
MACD (12, 26)
Sell
Level
-3.14
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Neutral
Level
6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.6108)
Sell
CA Score
(Annual)
Level (-1.0934)
Buy
Beneish M-Score
(Annual)
Level (-2.6625)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-4.858)
Buy
Piotroski F Score
(Annual)
Level (8)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue.
Stock Forecast FAQ
In the current month, MKSI has received 7 Buy ratings 2 Hold ratings, and 0 Sell ratings. The MKSI average analyst price target in the past 3 months is $121.96.
-
Where Will MKS Instruments Stock Be In 1 Year?
According to analysts, the consensus estimate is that MKS Instruments share price will rise to $121.96 per share over the next 12 months.
-
What Do Analysts Say About MKS Instruments?
Analysts are divided on their view about MKS Instruments share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that MKS Instruments is a Sell and believe this share price will drop from its current level to $70.00.
-
What Is MKS Instruments's Price Target?
The price target for MKS Instruments over the next 1-year time period is forecast to be $121.96 according to 9 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is MKSI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for MKS Instruments is a Buy. 7 of 9 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of MKSI?
You can purchase shares of MKS Instruments via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase MKS Instruments shares.
-
What Is The MKS Instruments Share Price Today?
MKS Instruments was last trading at $71.42 per share. This represents the most recent stock quote for MKS Instruments. Yesterday, MKS Instruments closed at $71.44 per share.
-
How To Buy MKS Instruments Stock Online?
In order to purchase MKS Instruments stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Is it Too Late to Buy Gold?
Amid deep uncertainties about the future of the US economy,…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is up 23.1% over the past day.
Sell
35
RGC alert for Apr 30
Regencell Bioscience Holdings [RGC] is down 11.18% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 14.88% over the past day.
